Download PDF
Kardiologie up2date 2009; 5(3): 259-271
DOI: 10.1055/s-0029-1215271
Bildgebung und interventionelle Techniken

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik der Kardiomyopathien mittels der kardialen Magnetresonanztomografie

Peter  Bernhardt, Nico  Merkle
Further Information

Publication History

Publication Date:
15 October 2009 (online)

Also available at
    Permissions and Reprints All articles of this category

Abstract

Cardiac magnetic resonance imaging (CMR) is a diagnostic multi-modality tool. It provides valuable information about myocardial function, morphology and tissue characterization. Cardiomyopathies are diseases of the heart with a broad spectrum of morphological and functional alterations. CMR offers differential diagnosis as well as prognostic information in these diseases and thus can guide specific treatment.

Literatur

  • 1 Aherne T, Tscholakaff D, Finkbeiner W. et al . Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression.  Circulation. 1986;  74 145-156
    PubMedGoogle Scholar
  • 2 Kim R J, Fieno D S, Parrish T B. et al . Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.  Circulation. 1999;  100 1992-2002
    CrossrefPubMedGoogle Scholar
  • 3 Marholdt H, Goedecke C, Wagner A. et al . Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology.  Circulation. 2004;  109 1250-1258
    CrossrefPubMedGoogle Scholar
  • 4 Vogelsberg H, Marholdt H, Deluigi C C. et al . Cardiovascular magnetic resonance in clinically suspected cardiac amyoloidosis: noninvasive imaging compared to endomyocardial biopsy.  J Am Coll Cardiol. 2008;  51 1022-1030
    CrossrefPubMedGoogle Scholar
  • 5 McCrohon J A, Moon J C, Prasad S K. et al . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium enhanced cardiovascular magnetic resonance.  Circulation. 2003;  108 54-59
    CrossrefPubMedGoogle Scholar
  • 6 Soriano , CJ , Ridocci F, Estornell J. et al . Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.  Int J Cardiol. 2007;  116 167-173
    CrossrefPubMedGoogle Scholar
  • 7 Zimmermann O, Grebe O, Merkle N. et al . Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy.  Eur J Heart Fail. 2006;  8 162-166
    CrossrefPubMedGoogle Scholar
  • 8 Assomull R G, Prasad S K, Lyne J. et al . Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.  J Am Coll Cardiol. 2006;  48 1977-1985
    CrossrefPubMedGoogle Scholar
  • 9 Wu K C, Weiss R G, Thiemann D R. et al . Late gadolinium enhancement by cardiovascular magnetic resonance heralds and adverse prognosis in nonischemic cardiomyopathy.  J Am Coll Cardiol. 2008;  51 2414-2421
    CrossrefPubMedGoogle Scholar
  • 10 Hombach V, Merkle N, Torzewski J. et al . Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy.  Eur Heart J. 2009;  nur Online, Zitat durch DOI: DOI: 10.1093/eurheartj/ehp293
    PubMedGoogle Scholar
  • 11 Nazarian S, Bluemke D A, Lardo A C. et al . Magnetic resonance assessment oft he substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.  Circulation. 2005;  112 2821-2825
    CrossrefPubMedGoogle Scholar
  • 12 Moon J C, Fisher N G, McKenna W J, Pennell D J. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography.  Heart. 2004;  90 645-649
    CrossrefPubMedGoogle Scholar
  • 13 Rickers C, Wilke N M, Jerosch-Herold M. et al . Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.  Circulation. 2005;  112 855-861
    CrossrefPubMedGoogle Scholar
  • 14 Moon J C, McKenna W J, McCrohon J A. et al . Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.  J Am Coll Cardiol. 2003;  41 1561-1567
    CrossrefPubMedGoogle Scholar
  • 15 Adabag A S, Maron B J, Appelbaum E. et al . Occurence and frequency of arrythmias in hypertropic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.  J Am Coll Cardiol. 2008;  51 1369-1374
    CrossrefPubMedGoogle Scholar
  • 16 Petersen S E, Jerosch-Herold M, Hudsmith L E. et al . Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.  Circulation. 2007;  115 2418-2425
    CrossrefPubMedGoogle Scholar
  • 17 Olivotto I, Maron M S, Autore C. et al . Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.  J Am Coll Cardiol. 2008;  52 559-566
    CrossrefPubMedGoogle Scholar
  • 18 Maron M S, Hauser T H, Dubrow E. et al . Right ventricular involvement in hypertrophic cardiomyopathy.  Am J Cardiol. 2007;  100 1293-1298
    CrossrefPubMedGoogle Scholar
  • 19 Abdel-Aty H, Cocker M, Strohm O. et al . Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.  J Magn Reson Imaging. 2008;  28 242-245
    CrossrefPubMedGoogle Scholar
  • 20 Hombach V, Merkle N, Kestler H A. et al . Characterization of patients with acute chest pain using cardiac magnetic resonance imaging.  Clin Res Cardiol. 2008;  97 760-767
    CrossrefPubMedGoogle Scholar
  • 21 Assomull R G, Lyne J C, Keenan N. et al . The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries.  Eur Heart J. 2007;  28 1242-1249
    CrossrefPubMedGoogle Scholar
  • 22 Marholdt H, Wagner A, Deluigi C C. et al . Presentation patterns of myocardial damage, and clinical course of viral myocarditis.  Circulation. 2006;  114 1581-1590
    CrossrefPubMedGoogle Scholar
  • 23 Lieberman E B, Hutchins G M, Herskowitz A. et al . Clinicopathologic description of myocarditis.  J Am Coll Cardiol. 1991;  18 1617-1626
    CrossrefPubMedGoogle Scholar
  • 24 Abdel-Aty H, Boyé P, Zagrosek A. et al . Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.  J Am Coll Cardiol. 2005;  45 1815-1822
    CrossrefPubMedGoogle Scholar
  • 25 Friedrich M G, Sechtem U, Schulz-Menger J. et al . Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.  J Am Coll Cardiol. 2009;  53 1475-1487
    CrossrefPubMedGoogle Scholar
  • 26 Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.  Circulation. 1999;  99 1091-1100
    CrossrefPubMedGoogle Scholar
  • 27 Calabrese F, Basso C, Carturan E. et al . Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses?.  Cardiovasc Pathol. 2006;  15 11-17
    CrossrefPubMedGoogle Scholar
  • 28 Fabre A, Sheppard M N. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death.  Heart. 2006;  92 316-320
    PubMedGoogle Scholar
  • 29 Sen-Chowdhry S, Syrris P, Ward D. et al . Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.  Circulation. 2007;  115 1710-1720
    CrossrefPubMedGoogle Scholar
  • 30 Awad M M, Calkins H, Judge D P. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.  Nat Clin Pract Cardiovasc Med. 2008;  5 258-267
    CrossrefPubMedGoogle Scholar
  • 31 McKenna W J, Thiene G, Nava A. et al . Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.  Br Heart J. 1994;  71 215-218
    CrossrefPubMedGoogle Scholar
  • 32 Midiri M, Finazzo M, Brancato M. et al . Arrhythmogenic right ventricular dysplasia: MR features.  Eur Radiol. 1997;  7 307-312
    CrossrefPubMedGoogle Scholar
  • 33 Tandri H, Macedo R, Calkins H. et al . Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study.  Am Heart J. 2008;  155 147-153
    CrossrefPubMedGoogle Scholar
  • 34 Sen-Chowdhry S, Prasad S K, Syrris P. et al . Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype.  J Am Coll Cardiol. 2006;  48 2132-2140
    CrossrefPubMedGoogle Scholar
  • 35 Maceira A M, Joshi J, Prasad S K. CMR in Amyloidosis.  Circulation. 2005;  111 186-193
    CrossrefPubMedGoogle Scholar
  • 36 Vignaux O, Dhote R, Duboc D. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast enhanced, and cine magnetic resonance imaging: initial results of a prospective study.  J Comput Assist Tomogr. 2002;  26(5) 762-767
    CrossrefPubMedGoogle Scholar
  • 37 Patel M R, Cawely P J, Heitner J F. Improved diagnostic sensitivity of contrast enhanced cardiac MRI for cardiac sarcoidosis. (Abstract).  Circulation. 2004;  108 (Suppl.) 645
    PubMedGoogle Scholar
  • 38 Kolnagou A, Michaelides Y, Kontos C. et al . Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.  Hemoglobin. 2008;  32 17-28
    CrossrefPubMedGoogle Scholar
  • 39 Pennell D J. T2* magnetic resonance and myocardial iron in thalassemia.  Ann N Y Acad Sci. 2005;  1054 373-378
    CrossrefPubMedGoogle Scholar
  • 40 Tanner M A, Galanello R, Dessi C. et al . A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.  Circulation. 2007;  115 1876-1884
    CrossrefPubMedGoogle Scholar
  • 41 Pilgrim T M, Wyss T R. Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: A systematic review.  Int J Cardiol. 2008;  124 283-292
    CrossrefPubMedGoogle Scholar
  • 42 Bybee K A, Kara T, Prasad A. et al . Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction.  Ann Intern Med. 2004;  141 858-865
    CrossrefPubMedGoogle Scholar
  • 43 Rolf A, Nef H M, Möllmann H. et al . Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy.  Eur Heart J. 2009;  30 1635-1642
    CrossrefPubMedGoogle Scholar
  • 44 Sutton R, Kanal E, Wilkoff B L. et al . Safety of magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI SureScan pacing system: clinical study design.  Trials. 2008;  9 68
    CrossrefPubMedGoogle Scholar

Dr. med. Peter Bernhardt

Universitätsklinikum Ulm
Klinik für Innere Medizin II

Albert-Einstein-Allee 23
89081 Ulm

Email: peter.bernhardt@uniklinik-ulm.de